<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01221142</url>
  </required_header>
  <id_info>
    <org_study_id>HfICHiC</org_study_id>
    <nct_id>NCT01221142</nct_id>
  </id_info>
  <brief_title>Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rijeka</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PharmamedMado d.o.o., Zagreb, Croatia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rijeka</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this pilot study the researchers will investigate efficacy of hypothermia in the early
      stage of treatment patients with primary intracerebral hemorrhage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this pilot trial is to determine whether hypothermia improves neurological
      outcome (measured as 3 and 6 months after the onset of symptoms using mRS, GOS and BI) in
      patients who has suffered a primary intracerebral hemorrhage. The patients with primary
      intracerebral hemorrhage presented with coma (GCS ≤ 8) and ICH score 2-4 will be included.
      Induction of hypothermia will be initiated within 6 hours of symptoms onset. Patients will be
      cooled to core temperature of 34°C during 24 hours using non-invasive temperature management
      (Cincinnati Sub-Zero). The temperature will be measured continuously by esophageal system.
      After 24 hours of successful cooling, the target temperature will be gradually raised to
      achieve slow re-warming of 0.5°C / 2 h until the core temperature reaches 36,5°C.

      During hypothermia ECG, blood pressure, oxygen saturation and intracranial pressure will be
      measured continuously and registered every 30 min. The first CT scan of the brain, after
      initial, will be done early after normothermia is reached.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date>June 2012</completion_date>
  <primary_completion_date>September 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurological outcome</measure>
    <time_frame>3 months after the onset</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurological outcome</measure>
    <time_frame>6 months after the onset</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of significant cardiac arrhythmias, infections, severe disturbances of electrolytes</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment>20</enrollment>
  <condition>Hypothermia</condition>
  <condition>Primary Intracerebral Hemorrhage</condition>
  <condition>Signs and Symptoms</condition>
  <arm_group>
    <arm_group_label>Hypothermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Cincinnati Sub-Zero Hyper-Hypothermia to core temperature of 34C for 24 hours, rewarming rate 0,5/2h until the patient reaches 36,5C</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cincinnati Sub-Zero,&quot; Blanketrol III&quot;</intervention_name>
    <arm_group_label>Hypothermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  GCS ≤ 8

          -  ICH score 2-4

          -  symptom onset within 6 hours

          -  ages 18 - 80

        Exclusion Criteria:

          -  pregnancy

          -  hemodynamical unstability

          -  recent myocardial infarction

          -  systolic blood pressure &lt; 90 mm Hg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Igor Antoncic, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intensive Care Unit, Departmen of Neurology, University Hospital Rijeka, Croatis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Igor Antoncic, MD, MSc</last_name>
    <phone>+38551658315</phone>
    <email>igor.antoncic@ri.t-com.hr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Intensive Care Unit, Department of Neurology, University Hospital Rijeka</name>
      <address>
        <city>Rijeka</city>
        <zip>51000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Igor Antoncic, MD, MSc</last_name>
      <phone>+38551658315</phone>
      <email>igor.antoncic@ri.t-com.hr</email>
    </contact>
    <investigator>
      <last_name>Sinisa Dunatov, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marina Bralic, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2010</study_first_submitted>
  <study_first_submitted_qc>October 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2010</study_first_posted>
  <last_update_submitted>December 27, 2010</last_update_submitted>
  <last_update_submitted_qc>December 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>University Hospital Rijeka, Igor Antončić MD</name_title>
  </responsible_party>
  <keyword>Hypothermia, ICH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Signs and Symptoms</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

